In a 43-year-old male smoker with hypertension, BMI 29.8 kg/m², total cholesterol 225 mg/dL, HDL‑C 48 mg/dL, and LDL‑C 139 mg/dL, what information is most critical to determine whether to initiate lipid‑lowering therapy?

10-Year ASCVD Risk Calculation

The most critical information needed is the patient's 10-year atherosclerotic cardiovascular disease (ASCVD) risk score, calculated using the ACC/AHA Pooled Cohort Equations. This single calculation will determine whether to initiate statin therapy in this 43-year-old man.

Why Risk Calculation is Essential

The current guidelines universally prioritize risk-based decision making over treating isolated lipid values 1, 2, 3. This patient has multiple risk factors but doesn't automatically qualify for statin therapy based on lipid levels alone—his LDL-C of 139 mg/dL falls below the 190 mg/dL threshold that would mandate treatment regardless of other factors 4, 5.

What the Risk Score Will Tell You

Using the ACC/AHA Pooled Cohort Equations with his data:

• Age: 43 years
• Sex: Male
• Total cholesterol: 225 mg/dL
• HDL-C: 48 mg/dL
• Systolic BP: 138 mm Hg (untreated hypertension)
• Current smoker: Yes
• Diabetes: Not mentioned (assume no)

The treatment threshold is ≥7.5% 10-year ASCVD risk 2, 3. At this threshold or above, moderate-to-high intensity statin therapy is recommended (Class I indication).

Risk Stratification and Treatment Algorithm

If 10-year risk ≥7.5%:

• Initiate moderate-intensity statin therapy (expected LDL-C reduction 30-50%) 2
• Target: LDL-C <100 mg/dL or ≥30% reduction from baseline 6
• Consider high-intensity statin if risk ≥20% for maximal benefit 2

If 10-year risk 5% to <7.5% (borderline):

• Risk-enhancing factors guide decision 2:
  • Family history of premature ASCVD (father's MI at 62 doesn't qualify—must be <55 in males)
  • Metabolic syndrome (likely present: BP 138/86, BMI 29.8, TG 190)
  • Consider coronary artery calcium (CAC) scoring if decision uncertain
  • If CAC ≥100 or ≥75th percentile → initiate statin 2

If 10-year risk <5%:

• Focus on intensive lifestyle modification
• Defer statin therapy 2

Critical Pitfalls to Avoid

Do not treat based on LDL-C alone in this patient. His LDL-C of 139 mg/dL is elevated but doesn't reach the 160-190 mg/dL range where treatment might be considered in low-risk individuals 4, 5. The 2013 ACC/AHA guidelines explicitly moved away from treating to arbitrary LDL-C targets in favor of risk-based treatment with proven statin intensities 7.

Do not overlook his modifiable risk factors during the risk discussion:

• Active smoking (20 pack-years)—most potent modifiable risk factor
• Prehypertension/Stage 1 hypertension (138/86 mm Hg)
• Overweight (BMI 29.8)
• Sedentary lifestyle
• Elevated triglycerides (190 mg/dL)

The Risk Discussion

Once you calculate his 10-year ASCVD risk, engage in a clinician-patient risk discussion covering 2:

1. His absolute risk number and what it means
2. Potential for ASCVD risk reduction with statin therapy (typically 25-35% relative risk reduction)
3. Importance of lifestyle modification regardless of statin decision
4. Potential adverse effects (myalgias, diabetes risk, liver enzyme elevation)
5. His preference for treatment

The risk calculator is available at tools.acc.org/ASCVD-Risk-Estimator-Plus and provides decision support after data entry 2.

Without the calculated 10-year ASCVD risk score, you cannot make an evidence-based decision about statin initiation in this patient. All other information—while important for comprehensive cardiovascular risk management—is secondary to this single calculation.